186 related articles for article (PubMed ID: 21184973)
21. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773
[TBL] [Abstract][Full Text] [Related]
22. Adolescents' cortisol responses to awakening and social stress; effects of gender, menstrual phase and oral contraceptives. The TRAILS study.
Bouma EM; Riese H; Ormel J; Verhulst FC; Oldehinkel AJ
Psychoneuroendocrinology; 2009 Jul; 34(6):884-93. PubMed ID: 19195792
[TBL] [Abstract][Full Text] [Related]
23. Food intake in healthy young adults: effects of time pressure and social factors.
Waterhouse J; Bailey L; Tomlinson F; Edwards B; Atkinson G; Reilly T
Chronobiol Int; 2005; 22(6):1069-92. PubMed ID: 16393709
[TBL] [Abstract][Full Text] [Related]
24. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
25. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives.
Rosenberg MJ; Waugh MS; Long S
J Reprod Med; 1995 May; 40(5):355-60. PubMed ID: 7608875
[TBL] [Abstract][Full Text] [Related]
26. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
27. Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive.
Westhoff C; Osborne LM; Schafer JE; Morroni C
Obstet Gynecol; 2005 Jul; 106(1):89-96. PubMed ID: 15994622
[TBL] [Abstract][Full Text] [Related]
28. Effect of the menstrual cycle on performance of intermittent, high-intensity shuttle running in a hot environment.
Sunderland C; Nevill M
Eur J Appl Physiol; 2003 Jan; 88(4-5):345-52. PubMed ID: 12527962
[TBL] [Abstract][Full Text] [Related]
29. Oral contraceptive effects on food choice during the follicular and luteal phases of the menstrual cycle. A laboratory based study.
Tucci SA; Murphy LE; Boyland EJ; Dye L; Halford JC
Appetite; 2010 Dec; 55(3):388-92. PubMed ID: 20561549
[TBL] [Abstract][Full Text] [Related]
30. ADMA concentration changes across the menstrual cycle and during oral contraceptive use: the Cardiovascular Risk in Young Finns Study.
Valtonen P; Punnonen K; Saarelainen H; Heiskanen N; Raitakari OT; Juonala M; Viikari JS; Alfthan G; Kähönen M; Laaksonen R; Lyyra-Laitinen T; Laitinen T; Heinonen S
Eur J Endocrinol; 2010 Feb; 162(2):259-65. PubMed ID: 19934267
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women.
Clendenen TV; Kim S; Moy L; Wan L; Rusinek H; Stanczyk FZ; Pike MC; Zeleniuch-Jacquotte A
Magn Reson Imaging; 2013 Jan; 31(1):1-9. PubMed ID: 22898693
[TBL] [Abstract][Full Text] [Related]
32. Quality of life in relation to psychosocial risk variables for eating disorders in women and men.
Sanftner JL
Eat Behav; 2011 Apr; 12(2):136-42. PubMed ID: 21385644
[TBL] [Abstract][Full Text] [Related]
33. Fluctuations in Metabolites and Bone Markers Across the Menstrual Cycle in Eumenorrheic Women and Oral Contraceptive Users.
He W; Dam TV; Thøgersen R; Hansen M; Bertram HC
J Clin Endocrinol Metab; 2022 May; 107(6):1577-1588. PubMed ID: 35213728
[TBL] [Abstract][Full Text] [Related]
34. Fasted plasma asprosin concentrations are associated with menstrual cycle phase, oral contraceptive use and training status in healthy women.
Leonard AN; Shill AL; Thackray AE; Stensel DJ; Bishop NC
Eur J Appl Physiol; 2021 Mar; 121(3):793-801. PubMed ID: 33289860
[TBL] [Abstract][Full Text] [Related]
35. Duration of oral contraceptive use predicts women's initial and subsequent subjective responses to sexual stimuli.
Renfro KJ; Rupp H; Wallen K
Horm Behav; 2015 Sep; 75():33-40. PubMed ID: 26204805
[TBL] [Abstract][Full Text] [Related]
36. Female social and sexual interest across the menstrual cycle: the roles of pain, sleep and hormones.
Guillermo CJ; Manlove HA; Gray PB; Zava DT; Marrs CR
BMC Womens Health; 2010 May; 10():19. PubMed ID: 20507626
[TBL] [Abstract][Full Text] [Related]
37. Oral contraceptive therapy modulates hemispheric asymmetry in spatial attention.
Cicinelli E; De Tommaso M; Cianci A; Colacurci N; Rella L; Loiudice L; Cicinelli MV; Livrea P
Contraception; 2011 Dec; 84(6):634-6. PubMed ID: 22078194
[TBL] [Abstract][Full Text] [Related]
38. Influence of menstrual cycle and hormonal contraceptive use on MS symptom fluctuations: A pilot study.
Taylor H; Alhasan S; Saleem M; Poole S; Jiang F; Longbrake EE; Bove R
Mult Scler Relat Disord; 2023 Sep; 77():104864. PubMed ID: 37480738
[TBL] [Abstract][Full Text] [Related]
39. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms.
Bancroft J; Rennie D
J Psychosom Res; 1993; 37(2):195-202. PubMed ID: 8463994
[TBL] [Abstract][Full Text] [Related]
40. Oral contraceptives positively affect mood in healthy PMS-free women: A longitudinal study.
Hamstra DA; de Kloet ER; de Rover M; Van der Does W
J Psychosom Res; 2017 Dec; 103():119-126. PubMed ID: 29167038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
